Annual Reports EMHA Report 2023 EMHA’s agenda of 2023 was filled with trips, meetings and events that put migraine on the agenda of European’s and worldwide organizations and policy makers. DOWNLOAD Finance Report 2023 DOWNLOAD EMHA Report 2022 EMHA’s agenda of 2022 was filled with trips, meetings and events that put migraine on the agenda
EMHA’s 2019 Activities report and agenda of 2019 was fulfilled with activities, meetings and actions under the campaign name of #LightToMigraine. Read the full activities report. Click here to read the complete report.
Have you got any question or query?Please contact us. Name * I’m a * Please choose an optionPatientHealthcare professionalIndustryPoliticianMediaOther Email * * Requiered field. Acceptance of privacy policy. Acceptance of communications. EMHA OFFICE Rue d’Egmont 11 1000 Brusels (Belgium) communications@emhalliance.org
People affected by migraine reluctant to see their doctor and keep their condition private at work due to fear of judgement, says study. The survey, conducted by the European Migraine & Headache Alliance (EMHA), found that the impact of migraine stigma was at the centre of their daily lives February 7, 2024. A new survey
INDIANAPOLIS, Sept. 27, 2018 Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Emgality™ (galcanezumab-gnlm) 120 mg injection for the preventive treatment of migraine in adults. Emgality offers a once-monthly, self-administered, subcutaneous injection. Emgality is contraindicated in patients with serious hypersensitivity to galcanezumab-gnlm or to any of the excipients. Emgality will be available
Copenhagen University is now offering a Master on Headache Disorders. It´s a continuing professional development programme for healthcare professionals. The programme of the Master on Headache Disorders requires a minimum of 6 individual visits to Copenhagen, Denmark over a two-year period: Modules 1 to 4 are organized with an e-learning self-study period followed by one week
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
